Ariad to Present Data from Phase 2 Trial of Brigatinib for Lung Cancer Patients
News
Ariad Pharmaceuticals will present data from the ongoing Phase 2 ALTA trial of its investigational lung cancer drug brigatinib at the upcoming 17th World Conference on Lung Cancer (WCLC). The ... Read more